Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-31 @ 11:57 PM
Study NCT ID:
NCT06517433
Status:
COMPLETED
Last Update Posted:
2024-07-24
First Post:
2024-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b
Sponsor:
Mersana Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-18
First Submit QC Date:
None
Study First Post Date:
2024-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2024-07-24
Last Update Post Date Type:
ACTUAL